These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23648340)
1. [Effects of polysomy 17 on HER-2 gene and protein expression and its clinicopathologic significance in breast cancer]. Li J; Xu BH; Wang JY; Li Q; Zhang P; Yuan P; Ma F; Fan Y; Cai RG; Li Q Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):84-8. PubMed ID: 23648340 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression]. Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563 [TBL] [Abstract][Full Text] [Related]
3. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing. Vanden Bempt I; Van Loo P; Drijkoningen M; Neven P; Smeets A; Christiaens MR; Paridaens R; De Wolf-Peeters C J Clin Oncol; 2008 Oct; 26(30):4869-74. PubMed ID: 18794552 [TBL] [Abstract][Full Text] [Related]
4. The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer. Hyun CL; Lee HE; Kim KS; Kim SW; Kim JH; Choe G; Park SY J Clin Pathol; 2008 Mar; 61(3):317-21. PubMed ID: 17761736 [TBL] [Abstract][Full Text] [Related]
6. HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases. Zhang H; Ren G; Wang X; Zhao J; Yao H; Bai Y; Bo W Breast Cancer Res Treat; 2012 Jul; 134(2):743-9. PubMed ID: 22678158 [TBL] [Abstract][Full Text] [Related]
7. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients. Kuo SJ; Wang BB; Chang CS; Chen TH; Yeh KT; Lee DJ; Yin PL; Chen M Taiwan J Obstet Gynecol; 2007 Jun; 46(2):146-51. PubMed ID: 17638622 [TBL] [Abstract][Full Text] [Related]
8. Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status. Wang S; Hossein Saboorian M; Frenkel EP; Haley BB; Siddiqui MT; Gokaslan S; Hynan L; Ashfaq R Mod Pathol; 2002 Feb; 15(2):137-45. PubMed ID: 11850542 [TBL] [Abstract][Full Text] [Related]
9. HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach. Ridolfi RL; Jamehdor MR; Arber JM Mod Pathol; 2000 Aug; 13(8):866-73. PubMed ID: 10955453 [TBL] [Abstract][Full Text] [Related]
10. [HER-2 overexpression and gene amplification of advanced breast cancers determined by fluorescence in situ hybridization in fine needle aspiration specimens]. Zhang Z; Zhao L; Guo H; Guo L; Ling Y; Xu X; Zhao H; Pan Q Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):183-7. PubMed ID: 24785277 [TBL] [Abstract][Full Text] [Related]
11. HER-2 protein overexpressing breast cancer without gene amplification shows higher hormone receptor expression than HER-2 protein overexpressing breast cancer with gene amplification. Koo JS; Jung W; Yang WI Int J Surg Pathol; 2011 Aug; 19(4):425-32. PubMed ID: 19666946 [TBL] [Abstract][Full Text] [Related]
13. Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer. Zhu X; Lu Y; Lu H; Yang W; Tu X; Cai X; Zhou X Hum Pathol; 2011 Oct; 42(10):1499-504. PubMed ID: 21676436 [TBL] [Abstract][Full Text] [Related]
14. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma. Couturier J; Vincent-Salomon A; Nicolas A; Beuzeboc P; Mouret E; Zafrani B; Sastre-Garau X Mod Pathol; 2000 Nov; 13(11):1238-43. PubMed ID: 11106082 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast. Shao MM; Zhang F; Meng G; Wang XX; Xu H; Yu XW; Chen LY; Tse GM Histopathology; 2011 Aug; 59(2):264-73. PubMed ID: 21884205 [TBL] [Abstract][Full Text] [Related]
16. Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification. Orsaria M; Khelifa S; Buza N; Kamath A; Hui P J Clin Pathol; 2013 Dec; 66(12):1070-5. PubMed ID: 23908451 [TBL] [Abstract][Full Text] [Related]
17. Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: a study at a tertiary cancer center. Murthy SS; Sandhya DG; Ahmed F; Goud KI; Dayal M; Suseela K; Rajappa SJ Indian J Pathol Microbiol; 2011; 54(3):532-8. PubMed ID: 21934215 [TBL] [Abstract][Full Text] [Related]
18. Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practice. Ma Y; Lespagnard L; Durbecq V; Paesmans M; Desmedt C; Gomez-Galdon M; Veys I; Cardoso F; Sotiriou C; Di Leo A; Piccart MJ; Larsimont D Clin Cancer Res; 2005 Jun; 11(12):4393-9. PubMed ID: 15958623 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for Her-2 status in breast cancer and its relationship to clinicopathological characteristics]. Li HH; Ma F; Zeng X; Wang JY; Yuan P; Fan Y; Xu BH Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):76-80. PubMed ID: 21418986 [TBL] [Abstract][Full Text] [Related]
20. [Her-2 amplification and p185 expression in invasive breast cancer cells in women]. Titi S Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]